Correlation Between Regeneron Pharmaceuticals and Papaya Growth

Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Papaya Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Papaya Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regeneron Pharmaceuticals and Papaya Growth Opportunity, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Papaya Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Papaya Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Papaya Growth.

Diversification Opportunities for Regeneron Pharmaceuticals and Papaya Growth

-0.31

Correlation Coefficient

Regeneron Pharmaceuticals  Papaya Growth

Very good diversification

The 3 months correlation between Regeneron and Papaya is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Papaya Growth Opportunity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Papaya Growth Opportunity and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Papaya Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Papaya Growth Opportunity has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Papaya Growth go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Papaya Growth

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 2.24 times less return on investment than Papaya Growth. But when comparing it to its historical volatility, Regeneron Pharmaceuticals is 1.73 times less risky than Papaya Growth. It trades about 0.02 of its potential returns per unit of risk. Papaya Growth Opportunity is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,080  in Papaya Growth Opportunity on February 29, 2024 and sell it today you would earn a total of  15.00  from holding Papaya Growth Opportunity or generate 1.39% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Regeneron Pharmaceuticals  vs.  Papaya Growth Opportunity

Regeneron Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Regeneron Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, Regeneron Pharmaceuticals is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Papaya Growth Opportunity

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Papaya Growth Opportunity are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Papaya Growth is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Regeneron Pharmaceuticals and Papaya Growth

The main advantage of trading using opposite Regeneron Pharmaceuticals and Papaya Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Papaya Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Papaya Growth will offset losses from the drop in Papaya Growth's long position.

The idea behind Regeneron Pharmaceuticals and Papaya Growth Opportunity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.